Solubility enhancement of biperidine HCl by complexation with hydroxypropyl β-cyclodextrin


  • Amit Dubey Himalayan Institute of Pharmacy and Research, Rajawala, Dehradun
  • Vikram Singh Himalayan Institute of Pharmacy and Research, Rajawala, Dehradun
  • Divya Juyal Himalayan Institute of Pharmacy and Research, Rajawala, Dehradun
  • Geeta Rawat Department of pharmaceutical sciences, HNB Garhwal Central University), Uttarakhand


β-Cyclodextrin, Biperiden HCl, Parkinson’s disease


Oral route is the simplest and easiest way of drug administration, because of the greater stability, lesser bulk, and cheap cost of production, accurate dosage and easy process, solid oral dosage forms have several advantages over other dosage forms. All the poor water soluble drugs after oral administrations are not well absorbed and thus leads to decrease in inherent efficiency of drugs. Therefore, for oral drug delivery system the improvement of drug solubility thereby its oral bio-availability is the most important aspect of drug development process. Biperiden HCl is a potent drug (Maximum daily dose is 16mg/day), having extensive first pass metabolism resulting in poor Bioavailability. The pharmacokinetic profile of this drug showed 33±5 % Bioavailability and 18-24 hours elimination half-life (t1/2). In the present study attempt has been made to prepare and characterize inclusion complex of Biperiden HCl with Hydroxypropyl β-Cyclodextrin. The inclusion complexes prepared by different methods i.e. Physical mixture, Kneading and Solvent evaporation methods. The prepared complexes were characterized using FT-IR. The inclusion complex prepared by Kneading method exhibited greatest enhancing in solubility and faster dissolution (93.98% drug release in 60 min) of Biperiden HCl.


Download data is not yet available.


Patil J S, Kadam D V, Marapur S C, et al. Inclusion complex system; A novel technique to improve the solubility and bioavailability of poorly soluble drugs: A Review. Int. J. Pharm. Sci. Vol.2, 2010, 29-34.

Loftsson Thorsteinn, Marcus E Brewster. Pharmaceutical applications of cyclodextrins. Journal of Pharmaceutical Sciences, 85(10), 1996, 1017-1026.

Marcus E Brewstera, Thorsteinn Loftsson. Cyclodextrin as pharmaceutical solubilizers. Adv. Drug Delivery Reviews. 59, 2007, 645-666.

K.P.R. Chowdary and G Kamalakara Reddy. Complexes of Nifedipine with β- and hydroxypropyl β-cyclodextrins in the design of Nifedipine SR tablets. Ind. J. of Pharm. Sci., Mar-Apr. 2002: 142-146.

Sanoferjan AM, Nanjundaswamy NG. Mahesh S and Narasimhamurty S. Formulation and evaluation of β-cyclodextrin complexes of tenoxicam. Ind. J. of Pharm. Sci., March 2000; 62(2): 119-121.

Loftsson T, Masson M, Brewster ME, Selfassociation of cyclodextrins and cyclodextrin complexes, J Pharm Sci, 93(5), 2004, 2307-2316.

Mallwswara Rao al. Int. J. of Research in Pharm. and Nano Sciences 2(6),2013,757-767.



How to Cite

Dubey, A., Singh, V., Juyal, D., & Rawat, G. (2015). Solubility enhancement of biperidine HCl by complexation with hydroxypropyl β-cyclodextrin. Journal of Applied Pharmaceutical Research, 3(2), 27-29. Retrieved from